Calibr-Skaggs & Merck Collaboration

The strategic collaboration between Calibr and Merck, which began in 2012, facilitated Calibr’s founding and initial growth. Merck has provided funding commitments to Calibr in excess of $56 million to support early stage discovery research, to which Merck was granted a right of first negotiation.